ERBB2 and breast cancer: Four breast cancer molecular subtypes have been described, namely, luminal A (hormone receptor positive, HER2 negative), luminal B (hormone receptor positive, HER2 positive), HER2-enriched (hormone receptor negative, HER2 positive), and triple-negative (hormone receptor negative, HER2 negative) subtypes.